Isis Pharmaceuticals Sitemap Patients | Careers | Contact Us About Isis Antisense Technology Drugs in Development Investors & Media Strategic Alliances close To: From: Send... Program Contact Us Antisense Technology Discovery Platform Basic Science Antisense Drugs Medicinal Chemistry Antisense Approaches Intellectual Property Publications New Articles... Antisense Technology Medicinal Chemistry/Formulations and Manufacturing Antisense Pharmacokinetics & Safety Antisense Evidence of Clinical Activity Cardiovascular Metabolic Cancer...

Other Therapeutic Areas Patients | Careers | Contact Us About Isis Antisense Technology Discovery Platform Intellectual Property Publications New Articles Antisense Technology... Medicinal Chemistry/Formulations and Manufacturing Antisense Pharmacokinetics & Safety Antisense Evidence of Clinical Activity Cardiovascular Metabolic Cancer Severe & Rare... CH Antiviral Res. 2011 Jan;89(1):54-63 Activating the Synthesis of Progerin, the Mutant Prelamin A in Hutchinson-Gilford Progeria Syndrome, with Antisense Oligonucleotides Fong LG...

Antisense Evidence of... Patients | Careers | Contact Us About Isis Antisense Technology Discovery Platform Intellectual Property Publications New Articles Antisense Technology... Medicinal Chemistry/Formulations and Manufacturing Antisense Pharmacokinetics & Safety Antisense Evidence of Clinical Activity Cardiovascular Metabolic Cancer Severe & Rare... / Neurodegenerative Other Therapeutic Areas Drugs in Development Investors & Media Strategic Alliances close To: From: Send Antisense Evidence of Clinical Activity Randomized Phase II Trial...

Isis Pharmaceuticals Publications Severe & Rare / Neurodegenerative Patients | Careers | Contact Us About Isis Antisense Technology Discovery Platform Intellectual Property... Publications New Articles Antisense Technology Medicinal Chemistry/Formulations and Manufacturing Antisense Pharmacokinetics & Safety Antisense Evidence of Clinical Activity... Analysis of wig-1 Pathways Sedaghat Y, Mazur C, Sabripour M, Hung G, Monia BP PLoS One. 2012;7(2):e29429 Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice...

Therapeutic Areas Patients | Careers | Contact Us About Isis Antisense Technology Drugs in Development Therapeutic Areas Cardiovascular Severe & Rare Metabolic Cancer Inflammation... in the discovery and development of an exciting new class of drugs called antisense drugs. With our proprietary drug discovery platform we can rapidly identify drugs, providing a wealth... designed to treat a variety of health conditions, including cardiovascular, severe and rare, neurologic and metabolic diseases and cancer. We and our partners are developing antisense...